Top Premarket Decliners
08:00 AM EST, 01/30/2023 (MT Newswires) -- CN Energy Group (CNEY) shares slumped 52% on a planned public offering of its securities. Movano Health (MOVE) shares tumbled 31%, adding to Friday's losses
Incannex Healthcare Limited (NASDAQ:IXHL) Short Interest Update
Incannex Healthcare Limited (NASDAQ:IXHL – Get Rating) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 11,00
WYNN, MLCO and ALLO Are Among After Hour Movers
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersGT Biopharma (NASDAQ:GTBP) shares increased by 7.4% to $0.91 during Wednesday's after-market session. The market value of their outstanding shares is at $33.0 million. Science 37 Hldgs (NASDAQ:
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 80.0% to $2.16 during Wednesday's pre-market session. The company's market cap stands at $6.7 million. First Wave BioPharma (NASDAQ:FWBI) stock m
Why EHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Gainers Inpixon (NASDAQ:INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a
Incannex Healthcare Limited (NASDAQ:IXHL) Short Interest Up 25.9% in December
Incannex Healthcare Limited (NASDAQ:IXHL – Get Rating) was the recipient of a large growth in short interest in the month of December. As of December 30th, there was short interest totalling 14,600 s
Incannex Healthcare Begins Interim Analysis of Ongoing Anxiety Trial
12:22 AM EST, 01/18/2023 (MT Newswires) -- Incannex Healthcare (ASX:IHL) began an interim analysis of recent data from an ongoing clinical trial investigating the use of the pharmaceutical firm's psyc
Sector Update: Health Care Stocks Sinking With Broader Markets Wednesday
02:08 PM EST, 01/18/2023 (MT Newswires) -- Health care stocks were mostly lower Wednesday afternoon, with the NYSE Health Care Index falling 0.7% and the Health Care Select Sector SPDR Fund (XLV) down
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
Australian biopharma company developing therapeutic cannabinoid products and psychedelic medicines Incannex Healthcare (NASDAQ:IXHL) announced that its Phase 2 clinical trial assessing proprietary psi
Loading...
No Stock Yet